Denmark to India: Kit Import Trade Route

The Denmark to India Kit corridor is one of India's established pharmaceutical import routes from Denmark, with 67 shipments documented worth a combined $11.5M USD. The route is dominated by M/S. CATALENT GERMANY SCHORNDORF GM , which alone accounts for roughly 97% of all import value, reflecting the consolidated nature of Denmark's kit export sector.

Across 14 active Denmark suppliers, the average shipment value stands at $172.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with kit's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 17.8%, placing it at rank #9 among India's top kit import origins globally.

On the Indian buyer side, key Indian importers include NOVO NORDISK INDIA PRIVATE LIMITED , CLIANTHA RESEARCH LIMITED, DHL LOGISTICS PRIVATE LIMITED and 9 others. NOVO NORDISK INDIA PRIVATE LIMITED is the single largest Indian importer with 14 shipments valued at $11.2M USD.

India's kit imports from Denmark are driven primarily by a handful of large-scale Denmark manufacturers. M/S. CATALENT GERMANY SCHORNDORF GM with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — Indian buyers benefit from Denmark supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M/S. CATALENT GERMANY SCHORNDORF GM , CHEMO GROUP-PHARMACEUTICALS SITES, XXED XXALTXXAREXXV — together account for 99% of total trade value on this route. The average shipment value of $172.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cagrisema (1.0mg/1.0mg)/ placebo (195 kit) (for research purposes only) (foc) and cagrisama (1.7 mg/1.7 mg) / placebo (for research purposes only) (66 kit) (foc) , suggesting that Indian buyers tend to consolidate orders across related product lines from the same Denmark supplier.

On the buying side, NOVO NORDISK INDIA PRIVATE LIMITED is the largest importer with 14 shipments worth $11.2M USD — representing 97% of all kit imports from Denmark on this route. A total of 12 buyers are active on this corridor.